Drug intelligence / Profile preview

lavandula angustifolia

Development stage
Phase 2
Lead developer
The Grasses of Eden
Administration
Intranasal, Oral, Topical
01

Overview

Lavandula angustifolia, commonly known as English lavender, is a plant extract with a long history of traditional medicinal use. It is recognized for its antibacterial, antifungal, antioxidant, anti-inflammatory, and antiviral properties. The plant extract is also known for its calming, anxiolytic, and sedative effects. It is being investigated as an ingredient in a nasal spray medical device, developed by The Grasses of Eden Ltd, intended to shorten the duration and mitigate the effects of mild to moderate COVID-19 infection. Additionally, lavender syrup has been studied for improving olfactory dysfunction in COVID-19 patients. Lavender is often sold as an herbal supplement and is classified as an herbal product.

Other names
English LavenderCommon LavenderTrue LavenderNarrow-leaved lavenderLavandaLavender Essential OilSpike LavenderGarden LavenderAlhucemaFrench LavenderLavande des AlpesLavande du JardinLavande EspagnoleLavande FineLavande FrançaiseLavandulaLavandula dentataLavandula latifoliaLavandula spicaLavandula stoechasLavandula vera
02

Targets

Sucrase-IsomaltaseSERT (Sodium-dependent serotonin transporter)CaV (Voltage-gated calcium channel protein complex)GABRR (GABA-A receptor subunit rho)TYR (Tyrosinase)PNLIP (Pancreatic triacylglycerol lipase)ButyrylcholinesteraseAcetylcholinesteraseElastaseAMY (Pancreatic alpha-amylase)NMDAR (Glutamate receptor ionotropic, NMDA)Rho-associated protein kinase 2–Beta-secretase 1 protein-protein interfaceMAOA (Monoamine oxidase A)

Beyond the preview

Go deeper on lavandula angustifolia.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lavandula angustifolia.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call